文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

超急性HIV-1感染期更强的固有免疫应答与急性逆转录病毒综合征相关

A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome.
PubMed 文献 · Clin Infect Dis · 2021-01-01

BACKGROUND: Acute retroviral syndrome (ARS) is associated with human immunodeficiency virus type 1 (HIV-1) subtype and disease progression, but the underlying immunopathological pathways are poorly understood.…

要点

  • 超急性HIV-1感染期较强固有免疫应答与急性逆转录病毒综合征独立相关。
  • IP-10>466.0 pg/mL可区分较强固有免疫应答,灵敏度84.2%、特异度100.0%。
  • IP-10可能作为较强固有免疫的候选生物标志物。

核心结论

  • 超急性HIV-1感染期较强的固有免疫应答与急性逆转录病毒综合征发生相关。
  • 血浆IP-10可能是较强固有免疫的候选生物标志物。

研究设计与样本

  • 研究分析来自肯尼亚、卢旺达、乌干达、赞比亚和瑞典的55名≥18.0岁志愿者在超急性HIV-1感染前后的血浆样本。
  • 超急性HIV-1感染定义为HIV-1抗体阴性且RNA或p24抗原阳性。
  • 急性逆转录病毒综合征基于11种症状用潜类别分析判定,采用逻辑回归分析免疫应答与急性逆转录病毒综合征的关联。

主要发现

  • 55名志愿者中31名(56%)发生急性逆转录病毒综合征。
  • 超急性HIV-1感染期IP-10升高14倍,在11种症状中的7种升高,并独立与急性逆转录病毒综合征相关。

关键数值与推荐

  • IP-10阈值>466.0 pg/mL区分较强免疫应答的灵敏度为84.2%(95%CI: 60.4-96.6),特异度为100.0%(95%CI: 90.3-100.0)。

临床怎么用

  • 超急性HIV-1感染期可关注IP-10水平以评估较强固有免疫应答。
  • 较强固有免疫应答者急性逆转录病毒综合征风险更高,需加强临床监测。
  • 研究结果可为利用固有免疫的疫苗候选设计提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute retroviral syndrome (ARS) is associated with human immunodeficiency virus type 1 (HIV-1) subtype and disease progression, but the underlying immunopathological pathways are poorly understood. We aimed to elucidate associations between innate immune responses during hyperacute HIV-1 infection (hAHI) and ARS. METHODS: Plasma samples obtained from volunteers (≥18.0 years) before and during hAHI, defined as HIV-1 antibody negative and RNA or p24 antigen positive, from Kenya, Rwanda, Uganda, Zambia, and Sweden were analyzed. Forty soluble innate immune markers were measured using multiplexed assays. Immune responses were differentiated into volunteers with stronger and comparatively weaker responses using principal component analysis. Presence or absence of ARS was defined based on 11 symptoms using latent class analysis. Logistic regression was used to determine associations between immune responses and ARS. RESULTS: Of 55 volunteers, 31 (56%) had ARS. Volunteers with stronger immune responses (n = 36 [65%]) had increased odds of ARS which was independent of HIV-1 subtype, age, and risk group (adjusted odds ratio, 7.1 [95% confidence interval {CI}: 1.7-28.8], P = .003). Interferon gamma-induced protein (IP)-10 was 14-fold higher during hAHI, elevated in 7 of the 11 symptoms and independently associated with ARS. IP-10 threshold >466.0 pg/mL differentiated stronger immune responses with a sensitivity of 84.2% (95% CI: 60.4-96.6) and specificity of 100.0% (95% CI]: 90.3-100.0). CONCLUSIONS: A stronger innate immune response during hAHI was associated with ARS. Plasma IP-10 may be a candidate biomarker of stronger innate immunity. Our findings provide further insights on innate immune responses in regulating ARS and may inform the design of vaccine candidates harnessing innate immunity.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hassan AS, Hare J, Gounder K, et al. A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome. Clin Infect Dis. 2021. PMID: 33588436. doi:10.1093/cid/ciab139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。